- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 10.06. | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | 331 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare: Incannex Announces Initiation of Research Coverage by Alliance Global Partners | 190 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | Incannex launches DReAMzz study for sleep apnea treatment | 2 | Investing.com | ||
| 14.05. | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | 427 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen | |
| 12.05. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 22.04. | Incannex begrüßt US-Erlass zur Beschleunigung von Therapien für psychische Erkrankungen | 1 | Investing.com Deutsch | ||
| 22.04. | Incannex supports White House order on mental health treatments | 4 | Investing.com | ||
| 22.04. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.03. | Incannex reaktiviert Aktienrückkaufprogramm nach Phase der Inaktivität | 2 | Investing.com Deutsch | ||
| 27.03. | Incannex resumes share buyback after period of inactivity | 1 | Investing.com | ||
| 27.03. | Incannex Healthcare: Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position | 1 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research | 2 | GlobeNewswire (USA) | ||
| 25.03. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.03. | Incannex reports $75M cash position with no debt after financing | 3 | Investing.com | ||
| 17.03. | Incannex erfüllt wieder NASDAQ-Mindestkursanforderung | - | Investing.com Deutsch | ||
| 17.03. | Incannex regains Nasdaq compliance with minimum bid price | 4 | Investing.com | ||
| 17.03. | Incannex Healthcare: Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement | 431 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact... ► Artikel lesen | |
| 12.03. | Incannex Stock Slides As $10 Million Capital Raise Funds Next Study For Sleep Apnea Treatment | 6 | Benzinga.com |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,790 | +1,67 % | ACHTUNG bei Eckert&Ziegler: Könnte die Aktie jetzt komplett einbrechen? - Meine Analyse im Detail | ||
| MCKESSON | 651,40 | +0,52 % | If You Invested $100 In McKesson Stock 5 Years Ago, You Would Have This Much Today | ||
| HEALWELL AI | 0,487 | -2,89 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| INSULET | 122,00 | -3,82 % | Insulet has a new chief R&D officer | ||
| LIFEWARD | 7,060 | +3,82 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| SENSEONICS | 5,850 | +0,86 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| IMUNON | 1,620 | 0,00 % | Imunon, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| LANTHEUS | 91,60 | +1,44 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,524 | -1,64 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-a-NET in the Meningioma Cohort of a Phase 1/2a Study | SEATTLE, June 03, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,600 | +1,08 % | Inspire Medical data highlights cardiovascular outcomes with neuromod for sleep apnea | ||
| INSPIREMD | 0,645 | +6,61 % | InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR | ||
| GT BIOPHARMA | 0,533 | +3,77 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,600 | 0,00 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 1,118 | +0,36 % | Myomo übertrifft Q1-Prognosen, Aktie gibt dennoch nach | ||
| INTELLIGENT BIO SOLUTIONS | 2,350 | +2,62 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen |
INCANNEX HEALTHCARE INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 3,230 Euro und damit -9,27 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.